DUBLIN, IRELAND--(Marketwired - November 02, 2015) - Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced it will host an investor day on Monday, November 9, 2015 in New York. The Company’s presentation will start promptly at 11:30 a.m. EST.
Presentations by Horizon’s senior management team will review company financials, provide a detailed overview of its orphan, specialty and primary care business units and business development strategy as well as address misinformation in the marketplace related to its business.
The live webcast and a replay may be accessed by visiting Horizon’s website at http://ir.horizon-pharma.com. Please connect to the Company’s website at least 15 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast.
About Horizon Pharma plc
Horizon Pharma plc is a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets seven medicines through its orphan, primary care and specialty business units. Horizon’s global headquarters are in Dublin, Ireland. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter or view careers on our LinkedIn page.
For Investor Day Inquiries:
Ami Bavishi
Burns McClellan
abavishi@burnsmc.com
Company Contacts:
Investors:
John Thomas
Executive Vice President, Strategy and Investor Relations
Investor-relations@horizonpharma.com
Tina Ventura
Vice President, Investor Relations
Investor-relations@horizonpharma.com
U.S. Media:
Geoff Curtis
Group Vice President, Corporate Communications
gcurtis@horizonpharma.com
Help employers find you! Check out all the jobs and post your resume.
